Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
What is prostate cancer? Prostate cancer is the most common cancer in men. It develops in the prostate gland, which is a walnut-sized gland that sits deep in the pelvis right beneath the bladder and in front of the rectum. The prostate gland produces seminal fluid that nourishes and transports sperm. Most prostate cancers are slow growing and are initially confined to the prostate gland. Some are more aggressive and spread quickly.
How does prostate cancer develop? In general, cancer develops when genetic material in cells changes abnormally and the cells begin growing out of control. When there are enough of these abnormal cells, they can form a tumor that may be felt on exam or seen on imaging.
We offer robust clinical trial programs for prostate cancer. These research studies evaluate new medical approaches, devices, drugs, and other treatments.
As a Stanford Health Care patient, you may be eligible to participate in open clinical trials. Open trials refer to studies currently recruiting participants or that may recruit participants in the near future. Closed trials are not currently enrolling, but similar studies may open in the future.
You can access Stanford’s expertise and compassionate care for any stage or type of prostate cancer at a location that is convenient for you. We always accept new patients, and we take many insurance plans, including Medicare and Medi-Cal.